GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIB | hg38_v1_chr9_-_14307928_14308073 | 0.43 | 2.6e-11 | Click! |
NFIX | hg38_v1_chr19_+_13024917_13024972, hg38_v1_chr19_+_12995554_12995608, hg38_v1_chr19_+_13023958_13024032, hg38_v1_chr19_+_12995467_12995500 | 0.30 | 6.3e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_9115907 Show fit | 59.11 |
ENST00000318602.12
|
alpha-2-macroglobulin |
|
chr16_+_176659 Show fit | 57.18 |
ENST00000320868.9
ENST00000397797.1 |
hemoglobin subunit alpha 1 |
|
chr16_+_172869 Show fit | 53.81 |
ENST00000251595.11
ENST00000397806.1 ENST00000484216.1 |
hemoglobin subunit alpha 2 |
|
chr3_+_45026296 Show fit | 49.31 |
ENST00000296130.5
|
C-type lectin domain family 3 member B |
|
chr7_+_94394886 Show fit | 48.03 |
ENST00000297268.11
ENST00000620463.1 |
collagen type I alpha 2 chain |
|
chr4_-_87529359 Show fit | 47.79 |
ENST00000458304.2
ENST00000282470.11 |
SPARC like 1 |
|
chr4_-_87529460 Show fit | 47.61 |
ENST00000418378.5
|
SPARC like 1 |
|
chr18_+_31591869 Show fit | 42.50 |
ENST00000237014.8
|
transthyretin |
|
chr4_-_87529092 Show fit | 40.24 |
ENST00000503414.5
|
SPARC like 1 |
|
chr6_-_158999748 Show fit | 40.15 |
ENST00000449822.5
|
radial spoke head 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 122.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.8 | 104.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
6.0 | 101.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
4.7 | 84.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
2.0 | 81.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
4.6 | 74.0 | GO:0032060 | bleb assembly(GO:0032060) |
24.5 | 73.5 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
6.1 | 72.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.1 | 71.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
6.4 | 70.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 615.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.5 | 575.5 | GO:0005615 | extracellular space(GO:0005615) |
1.3 | 489.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 487.1 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.6 | 140.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.3 | 88.1 | GO:0005796 | Golgi lumen(GO:0005796) |
1.9 | 87.8 | GO:0001533 | cornified envelope(GO:0001533) |
1.1 | 85.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
5.2 | 77.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
4.5 | 77.3 | GO:0033010 | paranodal junction(GO:0033010) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 221.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.6 | 206.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.3 | 166.2 | GO:0008201 | heparin binding(GO:0008201) |
9.6 | 143.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.4 | 138.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 127.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.6 | 99.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 87.5 | GO:0005516 | calmodulin binding(GO:0005516) |
1.7 | 81.7 | GO:0008009 | chemokine activity(GO:0008009) |
1.0 | 76.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 578.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.5 | 408.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.7 | 301.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
2.6 | 181.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 153.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
1.8 | 113.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.4 | 94.6 | PID FGF PATHWAY | FGF signaling pathway |
2.2 | 92.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.7 | 72.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.2 | 56.8 | ST ADRENERGIC | Adrenergic Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 227.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
2.7 | 129.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 97.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
5.7 | 96.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.2 | 86.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.9 | 85.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
3.8 | 84.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.3 | 81.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
4.5 | 81.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.1 | 81.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |